Light-Switchable Gene Expression via Recombinant Transcription Factor
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene expression systems face challenges such as pleiotropic effects, toxicity, high leakage expression, and low transfection efficiency, particularly with chemical and physical inducers, which limit their application in precise spatiotemporal control of gene expression in eukaryotic cells.
Innovation Solution
A light-switchable gene expression system comprising a recombinant transcription factor with a DNA-binding domain, a light-switchable domain derived from photosensitive proteins, and a transcriptional regulatory domain, allowing for spatiotemporal regulation of gene expression using light irradiation, and optionally hormone regulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chemical substance inducers are used to regulate gene expression, then gene expression can be induced, but pleiotropic effects and toxicity occur which interfere with endogenous gene expression
Solution Approach 1:
The patent replaces chemical substance inducers with light as a physical stimulus to control gene expression. The light-switchable transcription factor system uses optical energy instead of chemical energy, eliminating pleiotropic effects and toxicity associated with chemical inducers while maintaining reliable gene expression induction through wavelength-specific light activation.
Solution Approach 2:
The patent introduces a light-switchable transcription factor as an intermediary between light and gene expression. This intermediary protein contains a light-absorbing domain that converts optical energy into conformational changes, which then regulate transcriptional activity, thereby mediating the effect of light on target genes without direct chemical contact with cellular components.
2Reliability
If hormone inducers are used to regulate gene expression, then gene expression can be induced, but high leakage expression occurs in the absence of inducers
Solution Approach 1:
The patent employs a dynamic light-switchable transcription factor system where the transcriptional activity can be rapidly switched between active and inactive states by light irradiation. The light-absorbing domain undergoes reversible conformational changes in response to light, allowing precise temporal control of gene expression without the persistent basal activity (leakage) characteristic of hormone-induced systems.
3Reliability
If physical methods are used to induce gene expression, then gene expression can be regulated, but strong toxicity to cells occurs
Solution Approach 1:
The patent uses specific parameters of light (wavelength, intensity, duration) to control gene expression with high precision. By tuning the optical parameters to match the absorption spectrum of the light-switchable domain, the system achieves effective gene regulation at low light intensities that do not cause cellular damage, unlike harsh physical methods such as UV irradiation or heat shock.
4Reliability
If chemical-induced gene expression systems are used, then gene expression can be induced, but transfection efficiency is lower when consisting of two or more proteins
Solution Approach 1:
The patent merges the light-sensing function and transcriptional activation function into a single fused transcription factor protein. The light-switchable transcription factor contains both the light-absorbing domain and the transcriptional activation domain in one polypeptide chain, eliminating the need for separate transfection of multiple components and thereby improving transfection efficiency while maintaining reliable light-induced gene expression.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise and safe spatiotemporal control of gene expression with high resolution, reducing toxicity and leakage, and improving transfection efficiency, suitable for biomedical research and therapy.
Implementation Method 1
a second polypeptide as a light-absorbing domain, which is derived from a photosensitive protein containing a flavin chromophore
Implementation Method 2
a second polypeptide as a light-absorbing domain, which is derived from a photosensitive protein containing a flavin chromophore
Data Source
Figure 1~2
Figure 3~4
Figure 5
AI summary
Provided is an optically controlled gene expression system, comprising: a) a photosensitive recombinant transcription factor encodes a gene, the photosensitive recombinant transcription factor comprising a first polypeptide as the DNA bonding domain, a second polypeptide as the photosensitive domain, and a third polypeptide as the transcription regulatory domain; b) a target transcription unit comprising at least one reaction element identified and bound by the first polypeptide, and a promoter and a nucleotide sequence to be transcribed regulated by the third polypeptide. Also provided is a eukaryotic expression vector comprising said optically controlled gene expression system, and a method for regulating gene expression in a host cell by using the optically controlled gene expression system. Also provided is a reagent kit containing different components of the optically controlled gene expression system. The optically controlled gene expression system has a quick, effective and powerful induction, is safer than other inducers, is of little or no toxicity, and can control gene expression both spatially and temporally.